Rare diseases
Investigational molecules
Locations
Study of the use of tasadenoturev for children and young adults with recurrent or resistant high-grade brain tumors
The NetherlandsA study of pumitamig and a drug combination versus nivolumab and a drug combination for patients with untreated advanced or metastatic stomach or esophageal cancer
FranceA study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer
AustriaA study to evaluate the effectiveness of epcoritamab in patients with Waldenström's macroglobulinemia that has returned or has not responded to previous treatments.
BelgiumComparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma
BulgariaA study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis
BulgariaA study to compare glofitamab against a drug combination for patients with relapsed or refractory mantle cell lymphoma
FranceA study of progesterone after letrozole treatment for women with infertility undergoing intrauterine insemination
DenmarkA study of JNJ-78278343 and docetaxel compared to docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer
BelgiumA Phase 3 study to evaluate the efficacy and safety of ION582 in children and adults with Angelman syndrome
GermanyA study of allogeneic adipose-derived mesenchymal stem cells for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients
DenmarkA study to compare weekly or event-based use of doxycycline to prevent sexually transmitted infections in men who have sex with men and transgender women using HIV prevention medication.
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
